-+ 0.00%
-+ 0.00%
-+ 0.00%

Sagimet names Andreas Grauer chief medical officer as Eduardo Martins retires

PUBT·04/20/2026 11:01:36
Listen to the news
Sagimet names Andreas Grauer chief medical officer as Eduardo Martins retires
  • Sagimet Biosciences appointed Andreas Grauer as chief medical officer, effective April 20, 2026.
  • Grauer most recently served as chief medical officer at Omeros, leading clinical, safety, and medical functions for complement-targeted therapies.
  • Eduardo Bruno Martins retired as chief medical officer, effective April 20, 2026.
  • Martins will continue to support Sagimet as an external scientific advisor.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.